Andreas Meyer-Lindenberg (born 31 October 1965) is a German psychiatrist and professor in the Medical Faculty Mannheim at Heidelberg University.
His medical and scientific work took him via Bonn and Giessen, where he was trained as a neurologist, psychiatrist and psychotherapist, to the National Institute of Mental Health in Bethesda (Maryland).
The scientific focus of Andreas Meyer-Lindenberg's work is on researching risk and protective mechanisms in serious mental illnesses such as schizophrenia and depression using imaging, genetic and environmental methods.
Meyer-Lindenberg is a member of several Scientific Advisory Boards, including Brain Mind Institute – Swiss Federal Institutes of Technology Lausanne, Robert-Sommer Award for Schizophrenia Research, Research Priority Program on "Foundation of Human Social Behavior" – University of Zurich, The Loop Zurich – Medical Research Center, Endosane Pharmaceuticals, Neurotorium and The Brain Prize and a member of the board of several professional societies such as the German Society for Psychiatry and Psychotherapy, Psychosomatics and Neurology (DGPPN).
Andreas Meyer-Lindenberg is site spokesperson at the German Center for Mental Health and serves as Editor-in-Chief of Neuroscience Applied as part of the European College of Neuropsychopharmacology (ECNP) Executive Committee (2022–2025).